“…Using CGM, an evaluation of the glucose variability, the calculated interquartile range, was found to have 60% sensitivity and 98% specificity for identifying CFRD Positive predictive value for a diagnosis of CFRD was found to be 93% while negative predictive value was 83% . In patients aged 10 to 17 years, other CGM measures, hyperglycemia and glycemic variability, were found to be associated with FEV1pp and FVCpp decline in the prior year, but not weight or BMI z ‐score change . In adults, patients with higher CGM values, had poorer baseline lung function (by almost 20%), lower weight (~8 kg) and steeper FEV1pp decline (−1.34%).…”